Logo image of BTSGU

BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 (BTSGU) Stock Fundamental Analysis

NASDAQ:BTSGU - Nasdaq - US10950A2050 - Currency: USD

69.92  -3.97 (-5.37%)

Fundamental Rating

4

Taking everything into account, BTSGU scores 4 out of 10 in our fundamental rating. BTSGU was compared to 108 industry peers in the Health Care Providers & Services industry. BTSGU has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, BTSGU is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year BTSGU was profitable.
In the past year BTSGU had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BTSGU reported negative net income in multiple years.
Of the past 5 years BTSGU 4 years had a positive operating cash flow.
BTSGU Yearly Net Income VS EBIT VS OCF VS FCFBTSGU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

1.2 Ratios

BTSGU has a Return On Assets of -0.70%. This is comparable to the rest of the industry: BTSGU outperforms 51.40% of its industry peers.
BTSGU has a Return On Equity (-2.51%) which is in line with its industry peers.
The Return On Invested Capital of BTSGU (3.42%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for BTSGU is below the industry average of 8.14%.
Industry RankSector Rank
ROA -0.7%
ROE -2.51%
ROIC 3.42%
ROA(3y)-0.96%
ROA(5y)-0.86%
ROE(3y)-9.05%
ROE(5y)-7.04%
ROIC(3y)3.57%
ROIC(5y)3.15%
BTSGU Yearly ROA, ROE, ROICBTSGU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 -10 -20

1.3 Margins

With a Operating Margin value of 1.85%, BTSGU perfoms like the industry average, outperforming 45.79% of the companies in the same industry.
BTSGU's Operating Margin has declined in the last couple of years.
BTSGU has a Gross Margin of 14.50%. This is in the lower half of the industry: BTSGU underperforms 73.83% of its industry peers.
BTSGU's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.85%
PM (TTM) N/A
GM 14.5%
OM growth 3Y-17.41%
OM growth 5Y-7.89%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.74%
GM growth 5Y1.85%
BTSGU Yearly Profit, Operating, Gross MarginsBTSGU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 5 10 15

3

2. Health

2.1 Basic Checks

BTSGU has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BTSGU has been reduced compared to 1 year ago.
Compared to 1 year ago, BTSGU has an improved debt to assets ratio.
BTSGU Yearly Shares OutstandingBTSGU Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 50M 100M 150M
BTSGU Yearly Total Debt VS Total AssetsBTSGU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 3.83 indicates that BTSGU is not in any danger for bankruptcy at the moment.
BTSGU has a Altman-Z score of 3.83. This is in the better half of the industry: BTSGU outperforms 73.83% of its industry peers.
BTSGU has a debt to FCF ratio of 205.30. This is a negative value and a sign of low solvency as BTSGU would need 205.30 years to pay back of all of its debts.
BTSGU has a Debt to FCF ratio of 205.30. This is comparable to the rest of the industry: BTSGU outperforms 48.60% of its industry peers.
A Debt/Equity ratio of 1.63 is on the high side and indicates that BTSGU has dependencies on debt financing.
BTSGU has a Debt to Equity ratio of 1.63. This is in the lower half of the industry: BTSGU underperforms 74.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.63
Debt/FCF 205.3
Altman-Z 3.83
ROIC/WACC0.38
WACC8.94%
BTSGU Yearly LT Debt VS Equity VS FCFBTSGU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

2.3 Liquidity

BTSGU has a Current Ratio of 1.35. This is a normal value and indicates that BTSGU is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.35, BTSGU perfoms like the industry average, outperforming 41.12% of the companies in the same industry.
A Quick Ratio of 0.97 indicates that BTSGU may have some problems paying its short term obligations.
With a Quick ratio value of 0.97, BTSGU is not doing good in the industry: 71.96% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 0.97
BTSGU Yearly Current Assets VS Current LiabilitesBTSGU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 500M 1B

6

3. Growth

3.1 Past

The earnings per share for BTSGU have decreased strongly by -322.58% in the last year.
The Revenue has grown by 14.32% in the past year. This is quite good.
Measured over the past years, BTSGU shows a very strong growth in Revenue. The Revenue has been growing by 28.33% on average per year.
EPS 1Y (TTM)-322.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.54%
Revenue 1Y (TTM)14.32%
Revenue growth 3Y16.51%
Revenue growth 5Y28.33%
Sales Q2Q%28.82%

3.2 Future

Based on estimates for the next years, BTSGU will show a very strong growth in Earnings Per Share. The EPS will grow by 43.10% on average per year.
The Revenue is expected to grow by 11.54% on average over the next years. This is quite good.
EPS Next Y246.23%
EPS Next 2Y92.51%
EPS Next 3Y59.43%
EPS Next 5Y43.1%
Revenue Next Year27.21%
Revenue Next 2Y16.95%
Revenue Next 3Y14.82%
Revenue Next 5Y11.54%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BTSGU Yearly Revenue VS EstimatesBTSGU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
BTSGU Yearly EPS VS EstimatesBTSGU Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 1 1.5

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 148.77, the valuation of BTSGU can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as BTSGU.
BTSGU's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 29.63.
The Price/Forward Earnings ratio is 100.44, which means the current valuation is very expensive for BTSGU.
BTSGU's Price/Forward Earnings is on the same level as the industry average.
BTSGU is valuated expensively when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 148.77
Fwd PE 100.44
BTSGU Price Earnings VS Forward Price EarningsBTSGU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BTSGU is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as BTSGU.
Industry RankSector Rank
P/FCF 927.56
EV/EBITDA 39.19
BTSGU Per share dataBTSGU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

BTSGU's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BTSGU's earnings are expected to grow with 59.43% in the coming years.
PEG (NY)0.6
PEG (5Y)N/A
EPS Next 2Y92.51%
EPS Next 3Y59.43%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.20%, BTSGU has a reasonable but not impressive dividend return.
BTSGU's Dividend Yield is rather good when compared to the industry average which is at 2.95. BTSGU pays more dividend than 94.39% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.29, BTSGU pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.2%

5.2 History

BTSGU is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BTSGU Yearly Dividends per shareBTSGU Yearly Dividends per shareYearly Dividends per share 2024 2025 0.5 1 1.5

5.3 Sustainability

DPN/A
EPS Next 2Y92.51%
EPS Next 3Y59.43%
BTSGU Yearly Income VS Free CF VS DividendBTSGU Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27

NASDAQ:BTSGU (2/21/2025, 8:04:34 PM)

69.92

-3.97 (-5.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-01 2024-11-01/bmo
Earnings (Next)03-06 2025-03-06/bmo
Inst Owners47.01%
Inst Owner ChangeN/A
Ins Owners0.64%
Ins Owner ChangeN/A
Market Cap12.18B
Analysts84.44
Price Target79.27 (13.37%)
Short Float %0.02%
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield 3.2%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date01-15 2025-01-15 (0.8437)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-39.48%
Min EPS beat(2)-40.94%
Max EPS beat(2)-38.02%
EPS beat(4)2
Avg EPS beat(4)11.75%
Min EPS beat(4)-40.94%
Max EPS beat(4)77.58%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.62%
Min Revenue beat(2)2.41%
Max Revenue beat(2)4.83%
Revenue beat(4)3
Avg Revenue beat(4)3.75%
Min Revenue beat(4)-1.47%
Max Revenue beat(4)9.23%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.21%
PT rev (3m)24.98%
EPS NQ rev (1m)2.59%
EPS NQ rev (3m)1.85%
EPS NY rev (1m)0.78%
EPS NY rev (3m)-0.34%
Revenue NQ rev (1m)1.56%
Revenue NQ rev (3m)2.07%
Revenue NY rev (1m)0.34%
Revenue NY rev (3m)0.7%
Valuation
Industry RankSector Rank
PE 148.77
Fwd PE 100.44
P/S 1.15
P/FCF 927.56
P/OCF 127.41
P/B 7.54
P/tB N/A
EV/EBITDA 39.19
EPS(TTM)0.47
EY0.67%
EPS(NY)0.7
Fwd EY1%
FCF(TTM)0.08
FCFY0.11%
OCF(TTM)0.55
OCFY0.78%
SpS60.81
BVpS9.27
TBVpS-10.91
PEG (NY)0.6
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.7%
ROE -2.51%
ROCE 4.33%
ROIC 3.42%
ROICexc 3.44%
ROICexgc 15.92%
OM 1.85%
PM (TTM) N/A
GM 14.5%
FCFM 0.12%
ROA(3y)-0.96%
ROA(5y)-0.86%
ROE(3y)-9.05%
ROE(5y)-7.04%
ROIC(3y)3.57%
ROIC(5y)3.15%
ROICexc(3y)3.6%
ROICexc(5y)3.21%
ROICexgc(3y)19.01%
ROICexgc(5y)16.22%
ROCE(3y)4.53%
ROCE(5y)3.98%
ROICexcg growth 3Y-4.2%
ROICexcg growth 5YN/A
ROICexc growth 3Y-9.64%
ROICexc growth 5YN/A
OM growth 3Y-17.41%
OM growth 5Y-7.89%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.74%
GM growth 5Y1.85%
F-Score6
Asset Turnover1.83
Health
Industry RankSector Rank
Debt/Equity 1.63
Debt/FCF 205.3
Debt/EBITDA 6.65
Cap/Depr 41.09%
Cap/Sales 0.78%
Interest Coverage 0.81
Cash Conversion 24.12%
Profit Quality N/A
Current Ratio 1.35
Quick Ratio 0.97
Altman-Z 3.83
F-Score6
WACC8.94%
ROIC/WACC0.38
Cap/Depr(3y)33.49%
Cap/Depr(5y)32.43%
Cap/Sales(3y)0.88%
Cap/Sales(5y)0.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-322.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.54%
EPS Next Y246.23%
EPS Next 2Y92.51%
EPS Next 3Y59.43%
EPS Next 5Y43.1%
Revenue 1Y (TTM)14.32%
Revenue growth 3Y16.51%
Revenue growth 5Y28.33%
Sales Q2Q%28.82%
Revenue Next Year27.21%
Revenue Next 2Y16.95%
Revenue Next 3Y14.82%
Revenue Next 5Y11.54%
EBIT growth 1Y-35.64%
EBIT growth 3Y-3.78%
EBIT growth 5Y18.2%
EBIT Next Year74.79%
EBIT Next 3Y24.8%
EBIT Next 5YN/A
FCF growth 1Y477.48%
FCF growth 3Y-7.02%
FCF growth 5Y25.98%
OCF growth 1Y34.3%
OCF growth 3Y-1.81%
OCF growth 5Y22.49%